Novavax Cz A.S. Company Profile - Czech Republic | Financials & Key Executives

Novavax Cz A.S. (Czech Republic)

Main Activities: Pharmaceutical and Medicine Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers

Secondary Activities: All Other Miscellaneous Chemical Product and Preparation Manufacturing | Surgical and Medical Instrument Manufacturing | Other Miscellaneous Store Retailers | Research and Development in Nanotechnology | Materials Recovery Facilities

Full name: Novavax Cz A.S.

Profile Updated: December 05, 2025

Novavax Cz A.S. is an enterprise based in Czech Republic. Its main office is in Prague. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. Novavax Cz A.S. was incorporated on April 07, 2017. There are currently 20 - 24 (2025) people employed by Novavax Cz A.S.. From the latest financial highlights, Novavax Cz A.S. reported a net sales revenue drop of 55.76% in 2024. Its total assets decreased by 40.86% over the same period. The net profit margin of Novavax Cz A.S. increased by 8.15% in 2024.

Headquarters
Libalova 2348/1
Prague; The City of Prague; Postal Code: 14900

Contact Details: Purchase the Novavax Cz A.S. report to view the information.

Basic Information

Total Employees:

Purchase the Novavax Cz A.S. report to view the information.

Registered Capital:

Purchase the Novavax Cz A.S. report to view the information.

Financial Auditors:

Purchase the Novavax Cz A.S. report to view the information.

Incorporation Date:

April 07, 2017

Key Executives

Purchase this report to view the information.

Proxy

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Novavax Cz A.S. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.

Net sales revenue

-55.76%▼

Total operating revenue

87.39%▲

Operating profit (EBIT)

38.59%▲

EBITDA

-5.03%▼

Net Profit (Loss) for the Period

-10.23%▼

Total assets

-40.86%▼

Total equity

12.5%▲

Operating Profit Margin (ROS)

33.98%▲

Net Profit Margin

8.15%▲

Return on Equity (ROE)

-2.82%▼

Quick Ratio

-0.09%▼

Cash Ratio

0.25%▲

Similar companies

Related EMIS Industry Reports